Sharon Bio-Medicine has received an approval to introduce more profitable products, increase capacity utilization and get the business to move in the regulated markets specifically in the United States of America (USA). The board of directors at its meeting held on June 21, 2016 has decided for the same.
Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).